Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Managed Care Is Moving Toward Restricting DTC Advertised Drugs - Cigna VP

Executive Summary

Restrictions on direct-to-consumer advertised drugs are being considered by managed care organizations in order to control increasing costs driven by patient demand, Cigna Healthcare VP Peter Penna told an Institute for International Research conference Sept. 15.

You may also be interested in...



ProMedex DTC Antihistamine Counterdetail Aims To Enroll 3,000 in 60 Days

ProMedex' Symptom-Free allergy program to counter DTC-stimulated demand for antihistamines plans to enroll 3,000 patients with allergic rhinitis in the first two months.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel